A small proportion of previously ctDNA-detectable DNMT3A and TET2 variants (6/15) became undetectable in ctDNA samples at the time of CMR—such variants are therefore likely found exclusively in AITL cells and may be considered potential markers of MRD. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.